SB 122

  • Virginia Senate Bill
  • 2024 Regular Session
  • Introduced in Senate Jan 04, 2024
  • Senate
  • House
  • Governor

Pharmaceutical Services, Office of; establishes in Department of General Services, report.

Abstract

Department of General Services; Office of Pharmaceutical Services; report. Establishes in the Department of General Servicesan Office of Pharmaceutical Services to develop and execute a planto consolidate state agency prescription drug purchasing and pharmacybenefit management programs to increase efficiency in prescriptiondrug purchasing and constrain spending on prescription drugs. Thebill directs the Department to provide to the Governor and the GeneralAssembly an interim report on the development of the plan by November1, 2024, and a final report on the plan by November 1, 2025.

Bill Sponsors (2)

Votes


Actions


Feb 12, 2024

Senate

Passed by indefinitely in Finance and Appropriations (13-Y 1-N)

Feb 09, 2024

Senate

Impact statement from DPB (SB122S1)

Feb 07, 2024

Senate

Reported from General Laws and Technology with substitute (15-Y 0-N)

Senate

Senate committee, floor amendments and substitutes offered

Senate

Committee substitute printed 24106034D-S1

Senate

Rereferred to Finance and Appropriations

Jan 16, 2024

Senate

Impact statement from DPB (SB122)

Jan 04, 2024

Senate

Referred to Committee on General Laws and Technology

Senate

Prefiled and ordered printed; offered 01/10/24 24101273D

Bill Text

Bill Text Versions Format
Prefiled and ordered printed; offered 01/10/24 24101273D PDF HTML
Committee substitute printed 24106034D-S1 PDF HTML

Related Documents

Document Format
Fiscal Impact Statement: SB122FS1122.PDF PDF
Fiscal Impact Statement: SB122F122.PDF PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.